Evidence map›Paper›PMID 39254004›Full record

ReviewNanoscale horizons2024

The evolution of immune profiling: will there be a role for nanoparticles?

Olga E Eremina, Celine Vazquez, Kimberly N Larson, Anthony Mouchawar, Augusta Fernando, Cristina Zavaleta

Abstract readReview
In one paragraph

Review in Nanoscale horizons, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Olga E EreminaDepartment of Biomedical Engineering, University of Southern California, Los Angeles, California 90089, USA. fernaug01@gmail.com.ORCID 0000-0002-2776-4743
Celine VazquezDepartment of Biomedical Engineering, University of Southern California, Los Angeles, California 90089, USA. fernaug01@gmail.com.
Kimberly N LarsonDepartment of Biomedical Engineering, University of Southern California, Los Angeles, California 90089, USA. fernaug01@gmail.com.ORCID 0000-0002-1832-1078
Anthony MouchawarDepartment of Biomedical Engineering, University of Southern California, Los Angeles, California 90089, USA. fernaug01@gmail.com.
Augusta FernandoDepartment of Biomedical Engineering, University of Southern California, Los Angeles, California 90089, USA. fernaug01@gmail.com.
Cristina ZavaletaDepartment of Biomedical Engineering, University of Southern California, Los Angeles, California 90089, USA. fernaug01@gmail.com.ORCID 0000-0001-7314-2446

Funding

Supplement to Support the Development of a New Multiplexed Imaging Tool using Raman Spectroscopy for Breast CancerR01EB033918 · NIBIB · UNIVERSITY OF SOUTHERN CALIFORNIA · PI ZAVALETA, CRISTINA L. · 2023 to 2024
$1.4M
NIBIB NIH HHS R01 EB033918
6 · The paper itself

Abstract

Immune profiling provides insights into the functioning of the immune system, including the distribution, abundance, and activity of immune cells. This understanding is essential for deciphering how the immune system responds to pathogens, vaccines, tumors, and other stimuli. Analyzing diverse immune cell types facilitates the development of personalized medicine approaches by characterizing individual variations in immune responses. With detailed immune profiles, clinicians can tailor treatment strategies to the specific immune status and needs of each patient, maximizing therapeutic efficacy while minimizing adverse effects. In this review, we discuss the evolution of immune profiling, from interrogating bulk cell samples in solution to evaluating the spatially-rich molecular profiles across intact preserved tissue sections. We also review various multiplexed imaging platforms recently developed, based on immunofluorescence and imaging mass spectrometry, and their impact on the field of immune profiling. Identifying and localizing various immune cell types across a patient's sample has already provided important insights into understanding disease progression, the development of novel targeted therapies, and predicting treatment response. We also offer a new perspective by highlighting the unprecedented potential of nanoparticles (NPs) that can open new horizons in immune profiling. NPs are known to provide enhanced detection sensitivity, targeting specificity, biocompatibility, stability, multimodal imaging features, and multiplexing capabilities. Therefore, we summarize the recent developments and advantages of NPs, which can contribute to advancing our understanding of immune function to facilitate precision medicine. Overall, NPs have the potential to offer a versatile and robust approach to profile the immune system with improved efficiency and multiplexed imaging power.

Indexed as

NanoparticlesAnimalsHumansImmune SystemNeoplasmsPrecision Medicine

Identifiers

PMID39254004
PMCPMC11887860

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.